Fluorine in PDB 2x7e: Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol
Protein crystallography data
The structure of Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol, PDB code: 2x7e
was solved by
H.Y.K.Kaan,
V.Ulaganathan,
O.Rath,
C.Laggner,
H.Prokopcova,
D.Dallinger,
C.O.Kappe,
F.Kozielski,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
30.00 /
2.40
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
69.597,
79.849,
160.063,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.583 /
27.323
|
Other elements in 2x7e:
The structure of Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol
(pdb code 2x7e). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol, PDB code: 2x7e:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 2x7e
Go back to
Fluorine Binding Sites List in 2x7e
Fluorine binding site 1 out
of 4 in the Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1365
b:21.5
occ:1.00
|
FAG
|
A:X7E1365
|
0.0
|
21.5
|
1.0
|
CAW
|
A:X7E1365
|
1.3
|
21.3
|
1.0
|
CAV
|
A:X7E1365
|
2.3
|
22.2
|
1.0
|
CAN
|
A:X7E1365
|
2.4
|
20.7
|
1.0
|
FAF
|
A:X7E1365
|
2.6
|
25.9
|
1.0
|
CD2
|
A:LEU160
|
3.5
|
9.9
|
1.0
|
CE2
|
A:PHE239
|
3.5
|
12.6
|
1.0
|
CD2
|
A:PHE239
|
3.6
|
8.3
|
1.0
|
CAL
|
A:X7E1365
|
3.6
|
18.3
|
1.0
|
CAU
|
A:X7E1365
|
3.6
|
16.6
|
1.0
|
CAJ
|
A:X7E1365
|
4.1
|
17.8
|
1.0
|
CD2
|
A:LEU214
|
4.2
|
11.5
|
1.0
|
O
|
A:LEU214
|
4.5
|
15.7
|
1.0
|
CA
|
A:LEU214
|
4.6
|
14.0
|
1.0
|
CG
|
A:LEU160
|
4.7
|
10.8
|
1.0
|
CA
|
A:GLY217
|
4.7
|
15.3
|
1.0
|
OE2
|
A:GLU116
|
4.7
|
22.0
|
1.0
|
NH2
|
A:ARG221
|
4.7
|
25.5
|
1.0
|
CZ
|
A:PHE239
|
4.8
|
9.7
|
1.0
|
CB
|
A:LEU214
|
4.8
|
12.9
|
1.0
|
CG
|
A:PHE239
|
4.8
|
11.0
|
1.0
|
CAQ
|
A:X7E1365
|
4.9
|
12.7
|
1.0
|
CD2
|
A:LEU172
|
4.9
|
20.4
|
1.0
|
CD1
|
A:LEU160
|
4.9
|
4.8
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 2x7e
Go back to
Fluorine Binding Sites List in 2x7e
Fluorine binding site 2 out
of 4 in the Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1365
b:25.9
occ:1.00
|
FAF
|
A:X7E1365
|
0.0
|
25.9
|
1.0
|
CAV
|
A:X7E1365
|
1.3
|
22.2
|
1.0
|
CAW
|
A:X7E1365
|
2.3
|
21.3
|
1.0
|
CAL
|
A:X7E1365
|
2.4
|
18.3
|
1.0
|
FAG
|
A:X7E1365
|
2.6
|
21.5
|
1.0
|
CZ
|
A:ARG221
|
3.3
|
26.6
|
1.0
|
NH2
|
A:ARG221
|
3.3
|
25.5
|
1.0
|
CD2
|
A:LEU160
|
3.4
|
9.9
|
1.0
|
C
|
A:GLY217
|
3.4
|
14.5
|
1.0
|
NE
|
A:ARG221
|
3.5
|
27.5
|
1.0
|
CA
|
A:GLY217
|
3.5
|
15.3
|
1.0
|
CAN
|
A:X7E1365
|
3.6
|
20.7
|
1.0
|
CAJ
|
A:X7E1365
|
3.6
|
17.8
|
1.0
|
N
|
A:ALA218
|
3.6
|
12.2
|
1.0
|
NH1
|
A:ARG221
|
3.7
|
22.9
|
1.0
|
O
|
A:GLY217
|
3.9
|
12.8
|
1.0
|
CAU
|
A:X7E1365
|
4.1
|
16.6
|
1.0
|
CG
|
A:ARG221
|
4.1
|
18.9
|
1.0
|
CA
|
A:ALA218
|
4.2
|
12.1
|
1.0
|
CD
|
A:ARG221
|
4.2
|
23.0
|
1.0
|
O
|
A:LEU214
|
4.3
|
15.7
|
1.0
|
OE2
|
A:GLU116
|
4.6
|
22.0
|
1.0
|
N
|
A:GLY217
|
4.7
|
16.7
|
1.0
|
CD
|
A:GLU116
|
4.9
|
17.4
|
1.0
|
CB
|
A:ALA218
|
4.9
|
9.1
|
1.0
|
CG
|
A:LEU160
|
5.0
|
10.8
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 2x7e
Go back to
Fluorine Binding Sites List in 2x7e
Fluorine binding site 3 out
of 4 in the Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1365
b:25.1
occ:1.00
|
FAG
|
B:X7E1365
|
0.0
|
25.1
|
1.0
|
CAW
|
B:X7E1365
|
1.3
|
20.3
|
1.0
|
CAV
|
B:X7E1365
|
2.3
|
18.1
|
1.0
|
CAN
|
B:X7E1365
|
2.4
|
17.7
|
1.0
|
FAF
|
B:X7E1365
|
2.5
|
21.2
|
1.0
|
CD2
|
B:LEU160
|
3.3
|
8.4
|
1.0
|
CE2
|
B:PHE239
|
3.5
|
12.3
|
1.0
|
CAL
|
B:X7E1365
|
3.6
|
13.2
|
1.0
|
CD2
|
B:PHE239
|
3.7
|
9.1
|
1.0
|
CAU
|
B:X7E1365
|
3.7
|
14.5
|
1.0
|
CD2
|
B:LEU214
|
4.0
|
12.8
|
1.0
|
CAJ
|
B:X7E1365
|
4.1
|
16.0
|
1.0
|
O
|
B:LEU214
|
4.3
|
17.8
|
1.0
|
CA
|
B:LEU214
|
4.4
|
15.6
|
1.0
|
CD2
|
B:LEU172
|
4.4
|
15.7
|
1.0
|
CG
|
B:LEU160
|
4.5
|
11.0
|
1.0
|
CA
|
B:GLY217
|
4.6
|
18.8
|
1.0
|
CB
|
B:LEU214
|
4.7
|
14.8
|
1.0
|
CZ
|
B:PHE239
|
4.7
|
13.0
|
1.0
|
OE2
|
B:GLU116
|
4.8
|
21.3
|
1.0
|
CD1
|
B:LEU160
|
4.8
|
2.8
|
1.0
|
C
|
B:LEU214
|
4.8
|
16.8
|
1.0
|
CG
|
B:PHE239
|
4.9
|
10.1
|
1.0
|
CAQ
|
B:X7E1365
|
4.9
|
11.8
|
1.0
|
CB
|
B:LEU160
|
5.0
|
9.9
|
1.0
|
CG
|
B:LEU214
|
5.0
|
13.9
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 2x7e
Go back to
Fluorine Binding Sites List in 2x7e
Fluorine binding site 4 out
of 4 in the Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Human Kinesin EG5 in Complex with (R)-Fluorastrol within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1365
b:21.2
occ:1.00
|
FAF
|
B:X7E1365
|
0.0
|
21.2
|
1.0
|
CAV
|
B:X7E1365
|
1.3
|
18.1
|
1.0
|
CAW
|
B:X7E1365
|
2.3
|
20.3
|
1.0
|
CAL
|
B:X7E1365
|
2.4
|
13.2
|
1.0
|
FAG
|
B:X7E1365
|
2.5
|
25.1
|
1.0
|
CD2
|
B:LEU160
|
3.1
|
8.4
|
1.0
|
C
|
B:GLY217
|
3.4
|
18.0
|
1.0
|
CZ
|
B:ARG221
|
3.5
|
17.4
|
1.0
|
CA
|
B:GLY217
|
3.5
|
18.8
|
1.0
|
NH1
|
B:ARG221
|
3.5
|
15.6
|
1.0
|
CAN
|
B:X7E1365
|
3.6
|
17.7
|
1.0
|
CAJ
|
B:X7E1365
|
3.6
|
16.0
|
1.0
|
NE
|
B:ARG221
|
3.6
|
17.6
|
1.0
|
N
|
B:ALA218
|
3.8
|
15.8
|
1.0
|
O
|
B:GLY217
|
3.8
|
18.3
|
1.0
|
NH2
|
B:ARG221
|
3.9
|
15.8
|
1.0
|
CD
|
B:ARG221
|
4.0
|
16.6
|
1.0
|
CAU
|
B:X7E1365
|
4.1
|
14.5
|
1.0
|
OE2
|
B:GLU116
|
4.3
|
21.3
|
1.0
|
O
|
B:LEU214
|
4.3
|
17.8
|
1.0
|
CA
|
B:ALA218
|
4.4
|
15.4
|
1.0
|
CG
|
B:LEU160
|
4.6
|
11.0
|
1.0
|
CG
|
B:ARG221
|
4.6
|
17.5
|
1.0
|
N
|
B:GLY217
|
4.7
|
19.4
|
1.0
|
OE1
|
B:GLU162
|
4.9
|
22.8
|
1.0
|
|
Reference:
H.Y.K.Kaan,
V.Ulaganathan,
O.Rath,
H.Prokopcova,
D.Dallinger,
C.O.Kappe,
F.Kozielski.
Structural Basis For Inhibition of EG5 By Dihydropyrimidines: Stereoselectivity of Antimitotic Inhibitors Enastron, Dimethylenastron and Fluorastrol. J.Med.Chem. V. 53 5676 2010.
ISSN: ISSN 0022-2623
PubMed: 20597485
DOI: 10.1021/JM100421N
Page generated: Wed Jul 31 16:36:46 2024
|